Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
1 other identifier
observational
600
1 country
1
Brief Summary
Although one fourth of pregnant women experience at least 1 abortion, yet only 50% of causes are identified. Pregnancy loss can result from viral, bacterial, and other infections. It can reach the fetoplacental units through blood born or local spread. Lower genital tract infections- a potentially preventable infections- was suggested as a cause of spontaneous miscarriage. It was reported in 15 and 66% of early and late miscarriages respectively. These infections are also commonly encountered among apparently healthy looking pregnant women with an overall prevalence of 40-54%. If left untreated it can lead to premature rupture of the membranes, preterm birth, low birth weight, Fetal loss, neonatal ophthalmic and pulmonary damage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedFirst Submitted
Initial submission to the registry
November 2, 2019
CompletedFirst Posted
Study publicly available on registry
November 5, 2019
CompletedJuly 23, 2020
July 1, 2020
2 years
November 2, 2019
July 21, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the association of lower genital tract infection with spontaneous miscarriage
relation between genital tract infection and miscarriage
one year
Study Arms (2)
study group
The study group included 300 women presenting with unexplained spontaneous miscarriage or missed abortion during the first and early second trimester of pregnancy (8-16 weeks gestational age). The included women aged 18 to 45 years old.
control group
The control group included 300 women with normal pregnancy, recruited from women attending the antenatal clinic of gestational age 8-16 weeks. The included women aged 18 to 45 years old.
Interventions
three cervicovaginal swabs were obtained: one was used for a smear test of vaginal fluid pH evaluation and direct microscopy, the second swabs, cultured for aerobic and anaerobic bacteria and yeasts, the third was eluted in 2-sucrose-phosphate (2SP) based transport medium. Placental samples from the study group were cultured for aerobic and anaerobic bacteria. Placenta sample and 2SP medium were stored at -80°C until their analysis by real time PCR (qPCR)
Eligibility Criteria
The study group included 300 women presenting with unexplained spontaneous miscarriage. The control group included 300 women with normal pregnancy, recruited from women attending the antenatal clinic of gestational age 8-18 weeks. All participants were subjected to full history, careful general and abdominal examination, Cervicovaginal swabs, urine and blood sampling in addition to placental sampling from study group.
You may qualify if:
- women with unexplained spontaneous miscarriage or missed abortion during the first and early second trimester of pregnancy (8-16 weeks gestational age).
- women with normal pregnancy, attending the antenatal clinic of gestational age 8-16 weeks.
- The included women aged 18 to 45 years old.
You may not qualify if:
- women with miscarriage at a gestational age of more than 18 weeks,
- those with documented causes of miscarriage as fetal or uterine anomalies, antiphospholipid syndrome or endocrine factors and
- women who received recent antibiotic, antifungal or antiprotozoal treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
sahar M.Y elbaradie
Al Fayyum, Egypt
Biospecimen
cervicovaginal swabs, serum samples and placental tissues
Study Officials
- PRINCIPAL INVESTIGATOR
sahar MY Elbaradie, a.Professor
Fayoum University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate Professor
Study Record Dates
First Submitted
November 2, 2019
First Posted
November 5, 2019
Study Start
September 1, 2017
Primary Completion
August 30, 2019
Study Completion
September 30, 2019
Last Updated
July 23, 2020
Record last verified: 2020-07